551
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

CO binding improves the structural, functional, physical and anti-oxidation properties of the PEGylated hemoglobin

, , , , , , & show all
Pages 18-25 | Received 08 Nov 2013, Accepted 14 Jan 2014, Published online: 19 Mar 2014

References

  • Alayash AI, Patel RP, Cashon RE. 2001. Redox reactions of hemoglobin and myoglobin: biological and toxicological implications. Antioxid Redox Signal. 3:313–327.
  • Balakrishnan G, Zhao X, Podstawska E, Proniewicz LM, Kincaid JR, Spiro TG. 2009. Subunit-selective interrogation of CO recombination in carbonmonoxy hemoglobin by isotope-edited time-resolved resonance Raman spectroscopy. Biochemistry. 48:3120–3126.
  • Baldwin JM. 1980. The structure of human carbonmonoxy haemoglobin at 2.7 A resolution. J Mol Biol. 136:103–128.
  • Benesch RE, Benesch R, Yung S. 1973. Equations for the spectrophotometric analysis of hemoglobin mixtures. Anal Biochem. 55:245–248.
  • Caccia D, Ronda L, Frassi R, Perrella M, Del Favero E, Bruno S, et al. 2009. PEGylation promotes hemoglobin tetramer dissociation. Bioconjugate Chem. 20:1356–1366.
  • Carvalho FA, Santiago PS, Borges JC, Tabak M. 2011. Molecular masses and sedimentation coefficients of extracellular hemoglobin of Glossoscolex paulistus: alkaline oligomeric dissociation. Int J Biol Macromol. 48:183–193.
  • Cole RH, Vandegriff KD. 2011. MP4, a vasodilatory PEGylated hemoglobin. Adv Exp Med Biol. 701:85–90.
  • Conover CD, Malatesta P, Lejeune L, Chang CL, Shorr RG. 1996. The effects of hemodilution with polyethylene glycol bovine hemoglobin (PEG-Hb) in a conscious porcine model. J Investig Med. 44:238–246.
  • Dunne J, Caron A, Menu P, Alayash AI, Buehler PW, Wilson MT, et al. 2006. Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo. Biochem J. 399:513–524.
  • Elmer J, Alam HB, Wilcox SR. 2012. Hemoglobin-based oxygen carriers for hemorrhagic shock. Resuscitation. 83:285–292.
  • Hu T, Li D, Manjula BN, Acharya SA. 2008. Autoxidation of the site-specifically PEGylated hemoglobins: role of the PEG chains and the sites of PEGylation in the autoxidation. Biochemistry. 47:10981–10990.
  • Hu T, Li D, Manjula BN, Brenowitz M, Prabhakaran M, Acharya SA. 2009. PEGylation of Val-1(alpha) destabilizes the tetrameric structure of hemoglobin. Biochemistry. 48:608–616.
  • Hu T, Li D, Meng F, Prabhakaran M, Acharya SA. 2011. Increased inter dimeric interaction of oxy hemoglobin is necessary for attenuation of reductive pegylation promoted dissociation of tetramer. Artif Cells Blood Substit Immobil Biotechnol. 39:69–78.
  • Hu T, Manjula BN, Li D, Brenowitz M, Acharya SA. 2007. Influence of intramolecular cross-links on the molecular, structural and functional properties of PEGylated haemoglobin. Biochem J. 402: 143–151.
  • Hu T, Prabhakaran M, Acharya SA, Manjula BN. 2005. Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate. Biochem J. 392:555–564.
  • Huang ZF, Ye CH, Liu ZJ, Wang XJ, Chen HB, Liu YL, et al. 2012. Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column. Bioconjugate Chem. 23:740–750.
  • Iafelice R, Cristoni S, Caccia D, Russo R, Rossi-Bernardi L, Lowe KC, Perrella M. 2007. Identification of the sites of deoxyhaemoglobin PEGylation. Biochem J. 403:189–196.
  • Jahr JS, Akha AS, Holtby RJ. 2012. Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products. Curr Drug Discovery Technol. 9:158–165.
  • Kellett GL. 1971. Dissociation of hemoglobin into subunits. Ligand-linked dissociation at neutral pH. J Mol Biol. 59:401–424.
  • Kelly SM, Price NC. 2000. The use of circular dichroism in the investigation of protein structure and function. Curr Protein Pept Sci. 1:349–384.
  • Li C, Lin Q, Wang J, Shen L, Ma G, Su Z, Hu T. 2012. Preparation, structural analysis and bioactivity of ribonuclease A-albumin conjugate: tetra-conjugation or PEG as the linker. J Biotechnol. 162:283–288.
  • Li D, Hu T, Manjula BN, Acharya SA. 2009. Extension arm facilitated pegylation of alphaalpha-hemoglobin with modifications targeted exclusively to amino groups: functional and structural advantages of free Cys-93(beta) in the PEG-Hb adduct. Bioconjugate Chem. 20:2062–2070.
  • Lu XL, Zhao DX, Su ZG. 2004. Purification of hemoglobin by ion exchange chromatography in flow-through mode with PEG as an escort. Artificial Cells Blood Substitutes and Immobilization. Biotechnology. 32:209–227.
  • Lunelli L, Zuliani P, Baldini G. 1994. Evidence of hemoglobin dissociation. Biopolymers. 34:747–757.
  • Mu Q, Hu T, Yu J. 2013. Molecular insight into the steric shielding effect of PEG on the conjugated staphylokinase: biochemical characterization and molecular dynamics simulation. PLoS One. 8:e68559.
  • Pasut G, Veronese FM. 2012. State of the art in PEGylation: the great versatility achieved after forty years of research. J Control Release. 161:461–472.
  • Rameez S, Alosta H, Palmer AF. 2008. Biocompatible and biodegradable polymersome encapsulated hemoglobin: a potential oxygen carrier. Bioconjugate Chem. 19:1025–1032.
  • Ruckpaul K, Rein H, Jung F. 1971. Correlations between thermal stability and circular dichroism of hemoglobin derivatives of different species. FEBS Lett. 13:193–194.
  • Sakai H, Okuda N, Takeoka S, Tsuchida E. 2011. Increased viscosity of hemoglobin-based oxygen carriers retards NO-binding when perfused through narrow gas-permeable tubes. Microvasc Res. 81:169–176.
  • Sakai H, Takeoka S, Yokohama H, Seino Y, Nishide H, Tsuchida E. 1993a. Purification of concentrated hemoglobin using organic-solvent and heat-treatment. Protein Express Purif. 4:563–569.
  • Sakai H, Takeoka S, Yokohama H, Seino Y, Nishide H, Tsuchida E. 1993b. Purification of concentrated hemoglobin using organic solvent and heat treatment. Protein Express Purif. 4:563–569.
  • Snell SM, Marini MA. 1988. A convenient spectroscopic method for the estimation of hemoglobin concentrations in cell-free solutions. J Biochem Biophys Methods. 17:25–33.
  • Tsuchida E, Sou K, Nakagawa A, Sakai H, Komatsu T, Kobayashi K. 2009. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry. Bioconjugate Chem. 20:1419–1440.
  • Vandegriff KD, Malavalli A, Minn C, Jiang E, Lohman J, Young MA, et al. 2006. Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. Biochem J. 399:463–471.
  • Vandegriff KD, Young MA, Lohman J, Bellelli A, Samaja M, Malavalli A, Winslow RM. 2008. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol. 154: 1649–1661.
  • Winslow RM. 2000. Blood substitutes. Adv Drug Deliv Rev. 40: 131–142.
  • Winslow RM. 2004. MP4, a new nonvasoactive polyethylene glycol-hemoglobin conjugate. Artif Organs. 28:800–806.
  • Xue X, Li D, Yu J, Ma G, Su Z, Hu T. 2013. Phenyl linker- induced dense PEG conformation improves the efficacy of C-terminally monoPEGylated staphylokinase. Biomacromolecules. 14:331–341.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.